Atlas FDA

TENDRIL DX ENDOCARDIAL PACING LEADS

FDA premarket approval P960013/S004 · decided 1998-10-15

Approval details

PMA number
P960013
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TENDRIL DX ENDOCARDIAL PACING LEADS
Generic name
permanent pacemaker Electrode
Applicant
ABBOTT MEDICAL
Date received
1998-09-15
Decision date
1998-10-15
Days to decision
30 days
Decision code
OK30
Product code
DTB
Advisory committee
Cardiovascular
Expedited review
No
Location
Sylmar, CA
Statement
The 30-day Notice requested approval for use of parametric release as an alternate to the current use of biological indicators in the release of sterilized products.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18